(NASDAQ: CVRX) Cvrx's forecast annual revenue growth rate of 10.05% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.25%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.67%.
Cvrx's revenue in 2025 is $54,652,000.On average, 3 Wall Street analysts forecast CVRX's revenue for 2025 to be $1,467,974,723, with the lowest CVRX revenue forecast at $1,464,496,544, and the highest CVRX revenue forecast at $1,470,772,958. On average, 3 Wall Street analysts forecast CVRX's revenue for 2026 to be $1,713,879,384, with the lowest CVRX revenue forecast at $1,655,927,164, and the highest CVRX revenue forecast at $1,746,935,163.
In 2027, CVRX is forecast to generate $2,014,990,334 in revenue, with the lowest revenue forecast at $1,906,983,714 and the highest revenue forecast at $2,122,996,954.